A detailed history of Cambridge Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cambridge Trust CO holds 131,329 shares of BMY stock, worth $7.73 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
131,329
Previous 358,307 63.35%
Holding current value
$7.73 Million
Previous $18.4 Million 61.27%
% of portfolio
0.27%
Previous 0.78%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

SELL
$47.98 - $54.4 $10.9 Million - $12.3 Million
-226,978 Reduced 63.35%
131,329 $7.12 Million
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $4.12 Million - $4.92 Million
-84,966 Reduced 19.17%
358,307 $18.4 Million
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $3.39 Million - $3.79 Million
-58,581 Reduced 11.67%
443,273 $25.7 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $1.21 Million - $1.35 Million
-19,015 Reduced 3.65%
501,854 $32.1 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $2.9 Million - $3.29 Million
44,103 Added 9.25%
520,869 $36.1 Million
Q4 2022

Jan 09, 2023

BUY
$68.48 - $81.09 $3.63 Million - $4.3 Million
53,042 Added 12.52%
476,766 $34.3 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $489 - $289,456
3,767 Added 0.9%
423,724 $30.1 Million
Q2 2022

Aug 16, 2022

BUY
$72.62 - $79.98 $3.44 Million - $3.79 Million
47,410 Added 12.73%
419,957 $32.3 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $577,420 - $692,378
9,392 Added 2.59%
372,547 $27.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $682,334 - $795,441
12,723 Added 3.63%
363,155 $22.6 Million
Q3 2021

Nov 23, 2021

BUY
$59.17 - $69.31 $366,143 - $428,890
6,188 Added 1.8%
350,432 $20.7 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $913,525 - $1.07 Million
15,439 Added 4.7%
344,244 $20.4 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $100,046 - $108,950
-1,616 Reduced 0.49%
328,805 $22 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $532,873 - $599,325
8,980 Added 2.79%
330,421 $20.9 Million
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $1.55 Million - $1.76 Million
26,929 Added 9.14%
321,441 $19.9 Million
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $1,263 - $1,400
22 Added 0.01%
294,512 $17.8 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $1.04 Million - $1.21 Million
-18,948 Reduced 6.05%
294,490 $17.5 Million
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $537,451 - $781,041
11,583 Added 3.84%
313,438 $17.5 Million
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $7.82 Million - $10.2 Million
158,911 Added 111.17%
301,855 $19.4 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $4.72 Million - $5.59 Million
110,305 Added 337.95%
142,944 $7.25 Million
Q2 2019

Jul 29, 2019

SELL
$44.62 - $49.34 $180,800 - $199,925
-4,052 Reduced 11.04%
32,639 $0
Q1 2019

Apr 22, 2019

SELL
$45.12 - $53.8 $70,387 - $83,928
-1,560 Reduced 4.08%
36,691 $1.75 Million
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $86,061 - $111,600
-1,765 Reduced 4.41%
38,251 $1.99 Million
Q3 2018

Oct 22, 2018

SELL
$55.19 - $62.25 $1,379 - $1,556
-25 Reduced 0.06%
40,016 $2.48 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $6,720 - $8,376
-133 Reduced 0.33%
40,041 $2.22 Million
Q1 2018

Apr 27, 2018

BUY
$59.92 - $68.98 $76,398 - $87,949
1,275 Added 3.28%
40,174 $2.54 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $2.15 Million - $2.48 Million
38,899
38,899 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.